SEC 13F Intelligence

Mpm Bioimpact LLC / STOK

Mpm Bioimpact LLC’s Stoke Therapeutics Inc Position

Does Mpm Bioimpact LLC own Stoke Therapeutics Inc (STOK)? Yes — 767.0K shares worth $25M (+1.93% of its 13F portfolio) as of Q1 2026, down from 770.3K shares the prior filed quarter.

Position Value
$25M
Q1 2026
Shares
767.0K
% of Portfolio
+1.93%
Quarters Held
7
currently held

Position History STOK

Reported value by quarter
Q3 ’24: $6MQ3 ’24Q4 ’24: $8MQ4 ’24Q1 ’25: $5MQ1 ’25Q2 ’25: $9MQ2 ’25Q3 ’25: $19MQ3 ’25Q4 ’25: $24MQ4 ’25Q1 ’26: $25MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026767.0K$25M+1.93%
Q4 2025770.3K$24M+2.80%
Q3 2025789.7K$19M+3.04%
Q2 2025789.7K$9M+1.55%
Q1 2025694.0K$5M+0.79%
Q4 2024685.8K$8M+1.07%
Q3 2024479.5K$6M+0.88%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mpm Bioimpact LLC’s full portfolio or all institutional holders of STOK.